Opus Genetics, Inc.
IRD· Nasdaq
IRDOpus Genetics, Inc.
Filed Aug 9, 2011 · 10-Q · 40 days after period end · 0001140361-11-040635
| Metric | Q2 2011 | Q2 2010 |
|---|---|---|
| Revenue | $0.00 | $18.75K |
| Net Income | -$5.83M | -$3.60M |
| EPS Diluted | -$0.06 | -$0.05 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Opus Genetics, Inc. · CIK 1228627 · Engraved from SEC EDGAR
ended Jun 30, 2011 · filed Aug 9, 2011 · 40 d after period end
